EE371 Disease Management Costs for Patients With Intermediate-High or High-Risk Renal Cell Carcinoma (RCC) Following Nephrectomy
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.617
https://www.valueinhealthjournal.com/article/S1098-3015(22)02821-2/fulltext
Title :
EE371 Disease Management Costs for Patients With Intermediate-High or High-Risk Renal Cell Carcinoma (RCC) Following Nephrectomy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02821-2&doi=10.1016/j.jval.2022.09.617
First page :
Section Title :
Open access? :
No
Section Order :
10153